These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 921545)

  • 21. Application of antisera to interferon in studying oncogenic viruses.
    Inglot AD; Oleszak E
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):529-36. PubMed ID: 219809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Friend murine leukemia virus and spleen focus-forming virus expression in highly malignant interferon-sensitive and interferon-resistant Friend leukemia cells.
    Oppi C; Fiorucci G; Ferrantini M; Battistini A; Belardelli F
    Virology; 1986 Apr; 150(2):390-401. PubMed ID: 2421480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanisms of the stimulating action of the Rauscher leukemia virus on togavirus reproduction in the bodies of BALB/c strain mice].
    Pogodina VV; Malenko GV; Levina LS; Karmysheva VIa; Farutina LM
    Vopr Virusol; 1980; (4):449-54. PubMed ID: 6158796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by streptovaricins of Rauscher leukemia virus splenomegaly.
    Borden EC; Carter WA; Sensenbrenner LL; Owens AH; Lichtenstein J; Gray GD; Neil GL; Nichol FR; Li LH
    Int J Cancer; 1974 Dec; 14(6):817-25. PubMed ID: 4156850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous retroviral env expression in primary murine leukemias: lack of xenotropic antigens but presence of distinct mink cell focus-forming env subtypes correlating with ecotropic virus inoculated and mouse strain.
    Cloyd MW; Evans LH
    J Natl Cancer Inst; 1987 Jan; 78(1):181-9. PubMed ID: 3025502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Rauscher leukemia virus infection on BALB/c mouse embryos.
    Umar MH; van Griensven LJ
    J Natl Cancer Inst; 1976 Feb; 56(2):375-80. PubMed ID: 1255769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemic cell targeting and therapy by monoclonal antibody in a mouse model system.
    Scheinberg DA; Strand M
    Cancer Res; 1982 Jan; 42(1):44-9. PubMed ID: 6947860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody.
    Stockert E; DeLeo AB; O'Donnell PV; Obata Y; Old LJ
    J Exp Med; 1979 Jan; 149(1):200-15. PubMed ID: 216764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of a glycoprotein bearing a tumor transplantation antigen specific for Friend, Moloney, and Rauscher MuLV-induced tumors.
    Rogers MJ; Galetto G; Hearing VJ; Siwarski DF; Law LW
    J Immunol; 1984 Jun; 132(6):3211-7. PubMed ID: 6202777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell lines.
    Allen PT; Schellekens H; Van Griensven LJ; Billiau A
    J Gen Virol; 1976 Jun; 31(3):429-35. PubMed ID: 58965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement and suppression of DTH reactivity to Rauscher murine leukaemia virus induced tumour cell lines.
    Knulst AC; Berends D; Bazuin C; van Rooij HC; de Both NJ; Benner R
    Br J Cancer; 1989 Sep; 60(3):351-7. PubMed ID: 2477052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon and host resistance to Rauscher virus-induced leukemia.
    Glasgow LA; Friedman SB
    J Virol; 1969 Feb; 3(2):99-105. PubMed ID: 5774143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in spleen cellularity and erythrocyte accumulation following Rauscher virus infection in the mouse.
    Markoe AM; Okunewick JP
    Scand J Haematol; 1973; 10(4):273-81. PubMed ID: 4764609
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cytotoxic and blocking antibodies in the sera and eluates from spleen cells of mice with Rauscher leukemia following a different course].
    Ter-Grigorov VS; Dzagurov SG; Shevelev BI
    Biull Eksp Biol Med; 1975 Feb; 79(2):76-80. PubMed ID: 48386
    [No Abstract]   [Full Text] [Related]  

  • 35. [A peculiarity in the humoral immunity of BALB/C mice with Rauscher leukemia].
    Sokolov PP; Bergol'ts VM
    Biull Eksp Biol Med; 1976 Mar; 81(3):356-8. PubMed ID: 1085178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differences in the properties of the interferons produced by the leukocytes of healthy persons and of cancer and leukemia patients].
    Pokidysheva LN; Marchenko VI; Zubanova NA; Moĭsiadi SA; Fedorova IuB
    Vopr Virusol; 1979; (5):532-5. PubMed ID: 506207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell surface antigens of radiation leukemia virus-induced BALB/c leukemias defined by syngeneic cytotoxic T lymphocytes.
    Kaneko Y; Oettgen HF; Obata Y; Nakayama E
    Jpn J Cancer Res; 1989 Mar; 80(3):257-64. PubMed ID: 2542207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus.
    Risser R
    J Exp Med; 1979 May; 149(5):1152-67. PubMed ID: 448285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic control of antinuclear antibodies in mice infected with Rauscher leukemia virus.
    Varet B; Cannat A; Gisselbrecht S
    Cancer Res; 1977 Apr; 37(4):1115-8. PubMed ID: 300277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.